|
2CM9
The complement inhibitor OmCI in complex with ricinoleic acid
Deposited 2006-05-04
|
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
19–168(150 aa)
|
Mutation:YES
|
RCL RICINOLEIC ACID × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;30% PEG 4000 0.1 M SODIUM ACETATE PH 4.6 0.2 M AMMONIUM ACETATE
|
Resolution 2.30 Å
|
|
3ZUI
OMCI in complex with palmitoleic acid
Deposited 2011-07-19
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
19–168(150 aa)
|
Not recorded
|
PAM PALMITOLEIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;30% PEG 4000, 0.2 M MGCL2, 0.1 M TRIS PH 8.5.
|
Resolution 1.71 Å
R-free 0.223
|
|
3ZUO
OMCI in complex with leukotriene B4
Deposited 2011-07-19
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
19–168(150 aa)
|
Not recorded
|
LTB LEUKOTRIENE B4 × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
|
Resolution 1.86 Å
R-free 0.238
|
|
3ZUO
OMCI in complex with leukotriene B4
Deposited 2011-07-19
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
19–168(150 aa)
|
Not recorded
|
LTB LEUKOTRIENE B4 × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
|
Resolution 1.86 Å
R-free 0.238
|
|
3ZUO
OMCI in complex with leukotriene B4
Deposited 2011-07-19
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
19–168(150 aa)
|
Not recorded
|
LTB LEUKOTRIENE B4 × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
|
Resolution 1.86 Å
R-free 0.238
|
|
3ZUO
OMCI in complex with leukotriene B4
Deposited 2011-07-19
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
19–168(150 aa)
|
Not recorded
|
LTB LEUKOTRIENE B4 × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
|
Resolution 1.86 Å
R-free 0.238
|
|
5HCC
Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Dermacentor andersoni RaCI3.
Deposited 2016-01-04
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
19–168(150 aa)
|
Mutation:N78Q, N102Q
|
EDO 1,2-ETHANEDIOL × 7
CYS CYSTEINE × 1
DIO 1,4-DIETHYLENE DIOXIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;294 K;10% PEG 20K, 2% v/v 1,4 Dioxane, 0.1 M Bicine pH 9.0
|
Resolution 2.59 Å
R-free 0.267
|
|
5HCD
Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Rhipicephalus microplus RaCI2
Deposited 2016-01-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
19–168(150 aa)
Fragment:UNP residues 19-168
|
Mutation:N78Q, N102Q
|
CYS CYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;294 K;10% (w/v) PEG 20K, 2%(v/v)1,4 Dioxane, 0.1M Bicine pH 9.0
|
Resolution 2.98 Å
R-free 0.282
|
|
5HCE
Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Rhipicephalus appendiculatus RaCI1
Deposited 2016-01-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
19–168(150 aa)
Fragment:UNP residues 19-168
|
Mutation:N78Q, N102Q
|
CYS CYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;294 K;10% PEG 6K, 0.1 M Bicine pH 9.0
|
Resolution 3.12 Å
R-free 0.281
|
|
6RQJ
Structure of human complement C5 complexed with tick inhibitors OmCI, RaCI1 and CirpT1
Deposited 2019-05-15
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
19–168(150 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|